Balsalazide is an oral anti-inflammatory drug that is used for the treatment of ulcerative colitis.
Market Analysis and Insights: Global Balsalazide Market
Due to the COVID-19 pandemic, the global Balsalazide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Capsules accounting for % of the Balsalazide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Balsalazide market size is valued at US$ million in 2021, while the US and Europe Balsalazide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Balsalazide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Balsalazide include Salix Pharmaceuticals(Bausch Health), West-Ward Pharmaceuticals, Mylan, APOTEX, Par Pharmaceutical, Lupin Limited, Mysun Pharma and ANTER, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Balsalazide Scope and Segment
Balsalazide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Balsalazide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Capsules
Tablet
Segment by Application
Hospital
Drugstore
Online pharmacy
By Company
Salix Pharmaceuticals(Bausch Health)
West-Ward Pharmaceuticals
Mylan
APOTEX
Par Pharmaceutical
Lupin Limited
Mysun Pharma
ANTER
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Market Analysis and Insights: Global Balsalazide Market
Due to the COVID-19 pandemic, the global Balsalazide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Capsules accounting for % of the Balsalazide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Balsalazide market size is valued at US$ million in 2021, while the US and Europe Balsalazide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Balsalazide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Balsalazide include Salix Pharmaceuticals(Bausch Health), West-Ward Pharmaceuticals, Mylan, APOTEX, Par Pharmaceutical, Lupin Limited, Mysun Pharma and ANTER, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Balsalazide Scope and Segment
Balsalazide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Balsalazide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Capsules
Tablet
Segment by Application
Hospital
Drugstore
Online pharmacy
By Company
Salix Pharmaceuticals(Bausch Health)
West-Ward Pharmaceuticals
Mylan
APOTEX
Par Pharmaceutical
Lupin Limited
Mysun Pharma
ANTER
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
Pre-order Enquiry
Download Free Sample








